Related Experiment Video
Updated: Dec 25, 2025
05:25
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
1.1K
Revascularization for Coronary Artery Disease: Principle and Challenges
Dachuan Gu1, Jianyu Qu1, Heng Zhang1
1Department of Cardiovascular Surgery, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No.167 North Lishi Road, Xicheng District, Beijing, 100037, China.
Advances in Experimental Medicine and Biology
|April 5, 2020
Summary
Coronary revascularization strategies, including fibrinolysis, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG), are crucial for managing coronary artery disease. The choice depends on lesion complexity and patient factors for optimal outcomes.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Coronary artery disease (CAD) management relies heavily on revascularization strategies.
- Current approaches include fibrinolysis, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG).
Purpose of the Study:
- To review prevalent coronary revascularization methods.
- To discuss evidence on mechanisms, indications, techniques, and outcomes.
- To guide decision-making for optimal patient care in CAD.
Main Methods:
- Literature review of current coronary revascularization approaches.
- Analysis of evidence regarding fibrinolysis, PCI, and CABG.
- Discussion of factors influencing treatment choice, including lesion complexity and comorbidities.
Main Results:
- Fibrinolysis improves outcomes for ST-elevation myocardial infarction.
- PCI is frequently performed, with stent evolution enhancing results.
- CABG is most effective for stenotic arteries, especially complex lesions (left main, multivessel disease).
- Multidisciplinary decisions are essential, considering patient condition and comorbidities like heart failure and diabetes.
Conclusions:
- Coronary revascularization choice (PCI vs. CABG) requires careful consideration of lesion complexity and patient factors.
- CABG offers more complete revascularization for complex CAD.
- Routine invasive strategies and secondary prevention are recommended for patients with comorbidities and undergoing revascularization.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
180
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
180
01:28Acute Coronary Syndrome IV: Interprofessional Care
170
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
170
01:26Atherosclerosis III: Management
265
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
265
01:17Ischemic Heart Disease: Overview
2.6K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
01:27Peripheral Artery Disease III: Interprofessional Care
180
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
180
01:26Angina IV: Management
188
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
188